Gilotrif (afatinib) could be a cancer medication that interferes with the expansion and unfold of cancer cells within thebody.
Gilotrif is employed to treat non-small cell carcinoma that has unfold to alternative elements of the body.
Gilotrif can also be used for functions unlisted during this medication guide.
Submit your review
Get emergency medical help if you have any signs of an allergic reaction to Gilotrif: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Gilotrif and call your doctor at once if you have:
severe skin reaction that causes blistering and peeling;
blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;
eye problems - eye pain or redness, blurred vision, watery eyes, feeling like something is in your eye, increased sensitivity to light;
heart problems - pounding heartbeats or fluttering in your chest, shortness of breath (even with mild exertion), swelling, rapid weight gain;
liver problems - nausea, upper stomach pain, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
lung problems - fever, chest pain, dry cough, wheezing.
Common Gilotrif side effects may include:
mild diarrhea for 1 day or less;
nausea, vomiting, loss of appetite;
acne, dry skin, mild itching or skin rash; or
redness, pain, swelling, or other signs of infection around your fingernails or toenails.
The recommended dose of GILOTRIF is 40 mg orally once daily until disease progression or no longer tolerated by the patient. Take GILOTRIF at least 1 hour before or 2 hours after a meal. Do not take a missed dose within 12 hours of the next dose.